Join
Live feed
·
PRReleasevia Quantisnow
First Wave BioPharma Inc. logo

First Wave BioPharma Announces Two Abstracts on Celiac Disease Research Accepted for Presentation at the 2024 Digestive Disease Week (DDW) Conference

ByQuantisnow·Wall Street's wire, on your screen.
FWBI· First Wave BioPharma Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track FWBI (First Wave BioPharma Inc.) and more on Quantisnow.